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Imaging plays a vital role in the diagnosis and management of rheumatological disorders. 
Traditionally plain film radiography was widely used in arthropathies to assess periarticular bony 
changes, which often reflect established changes at the late stage of disease and thus have limited 
value in early diagnosis and disease monitoring. 
Magnetic resonance imaging (MRI) has become an important imaging modality in rheumatological 
disorders due to its ability to assess both morphological as well as functional changes, and plays a 
significant role in early diagnosis, monitoring disease evolution, assessing treatment responses and 
prognostication. More recently, advances in hardware and novel imaging sequences have aided the 
development of new MRI techniques; for example, whole-body MRI (WB-MRI) is gaining popularity 
and allows assessment of the overall inflammatory status in arthritis, whilst quantitative MRI 
shows promise in allowing more objective evaluation and standardisation of imaging-based 
assessment of inflammatory arthritis.  
The role of other emerging imaging techniques including high-resolution peripheral quantitative 
computed tomography (HR-pQCT) in early detection and monitoring of periarticular bone damage, 
fluorescence optical imaging (FOI) in visualisation of active inflammation, and molecular imaging in 
investigation of pathogenesis and disease evaluation on a cellular level will also be discussed. 
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Introduction 
Plain radiography has in the past been the primary imaging tool for the investigation of 
arthropathies. Radiographic features of the various types of arthritis have been extensively 
described in the literature and previously in this journal. However, structural bony changes, such as 
sclerosis and erosions, seen on radiographs, occur late in the course of disease and early changes 
are not apparent. The sensitivity of plain films is low and disease activity cannot be adequately 
assessed. Pelvic and lumbar spine radiography incurs a relatively high dose of ionising radiation; 
for example, the dose of an AP radiograph of the pelvis is 35 times that of a chest X-ray, and should 
be avoided where possible, particularly in children and adolescents. Magnetic resonance imaging 
(MRI) and ultrasound scanning are being used increasingly for the early diagnosis of arthropathies, 
and this facilitates early treatment that may prevent progression to irreversible structural damage. 
In this article we describe recent advances in the imaging of rheumatological diseases. For a more 
in-depth review of the role of ultrasound, the interested reader is referred to the dedicated 
ultrasound chapter in this publication. 
 
Magnetic resonance imaging 
MRI has emerged as the most sensitive imaging modality for detecting arthritis and discriminating 
between acute and chronic inflammation. In recent years, substantial technical advances have been 
made in software and hardware, such as phased array coils, higher performance gradients, parallel 
imaging and advanced post-processing techniques. These advances have led to reduction in scan 
times and improved image quality. Other advances include isotropic 3D-imaging techniques, which 
reduce partial volume artefact and allow reformatting in multiple planes for improved visualisation 
of anatomy and pathology. High-field strength systems (e.g. 3T MRI) are increasingly being used in 
clinical practice, providing increased spatial resolution and signal-to-noise ratio. 
Applications of morphological MRI and common findings 
Conventionally, morphological and contrast-enhanced MRI are used to assess inflammatory 
arthritis. In general, short tau inversion recovery (STIR) and contrast-enhanced T1-weighted 
images are useful for assessing active inflammation. 
In rheumatoid arthritis (RA) the diseased joints show proliferative synovitis on MRI. This 
inflammation leads to bone erosions, which in the acute phase demonstrate loss of cortical 
definition and presence of subcortical bone marrow oedema (osteitis). These are seen as high signal 
on STIR (which is fluid-sensitive) and contrast-enhanced images. Mature erosions show sharply 
marginated areas of trabecular bone loss with cortical defects. Tenosynovitis, a common finding, is 
seen as synovial sheath thickening with marked enhancement on post-contrast images.  
In axial and peripheral spondyloarthropathies, sacroiliitis is a common feature and is seen on MRI 
as subchondral bone marrow oedema, synovitis, capsulitis and enthesitis. In the new Assessment of 
Spondyloarthritis International Society (ASAS) criteria for axial spondyloarthritis1, the presence of 
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subchondral bone marrow oedema is mandatory for the diagnosis of acute sacroiliitis. In chronic 
sacroiliitis, periarticular fat metaplasia, sclerosis and erosions are seen, followed by ankylosis in 
some patients. Active spondylitis is seen as facet and costovertebral joint synovitis, enthesitis of 
spinal ligaments and corner inflammatory lesions due to bone marrow oedema of vertebral 
entheses. Fatty deposition at vertebral corners (fatty Romanus lesions) is highly specific for axial 
spondyloarthropathy.  
New MR techniques and clinical applications 
Whole-body MRI (WB-MRI): in recent years WB-MRI has been employed for the assessment of 
rheumatological diseases with multifocal and systemic involvement. It can detect inflammation at 
multiple sites, some of which may be subclinical, thus allowing estimation of total disease load and 
activity. WB-MRI also facilitates visualisation of enthesitis at multiple sites (Figure 1). A 
standardised scoring system based on WB-MRI is under development.1  
Quantitative MRI: Conventional analysis of MRI studies is subjective and relies on the experience 
and expertise of the reading radiologist. Quantitative methods provide objective evaluation and 
have the potential for automation and standardisation, and have been explored in randomised 
clinical trials to evaluated treatment response.3 Novel quantitative MRI techniques include 
diffusion-weighted imaging (DWI), dynamic contrast enhancement (DCE) and chemical shift-
encoded (CSE) MRI.   
DWI-MRI measures the mobility of free water in living tissue, where areas of active inflammation 
have increased free water content that results in increased diffusivity. Apparent diffusion 
coefficient (ADC) values in these regions are higher than in non-inflamed tissue (Figure 2), and have 
been used to evaluate sacroiliitis and as a biomarker for measuring treatment response.4 
DCE-MRI utilises serial imaging at short intervals (typically few seconds) during intravenous 
contrast administration. The dynamic enhancement profiles (time vs signal intensity) of the 
diseased region differ to normal tissue due to presence of inflammation and neoangiogenesis, and 
have been shown to correlate with disease activity and predict progression of erosive disease.5 It is 
also possible to derive quantitative physiological parameters by fitting dynamic enhancement data 
to pharmacokinetic models, which reflect exchanges between plasma and extracellular 
extravascular space. Such absolute parameters have the advantage of being independent of MRI 
hardware and parameters, and have shown promises in detecting synovial inflammation in early 
arthritis and assessment of tissue microcirculation.0 
CSE-MRI utilises the small difference between the precession frequencies of water and fat protons 
when exposure to a strong external magnetic field (i.e. inside an MRI scanner). This phenomenon 
allows quantitative measurement of water and fat composition, and by the same token bone 
marrow oedema and fat metaplasia, which reflect active inflammation and structural damage 
respectively in inflammatory arthritis (Figure 3). This technique has been successfully applied in a 
cohort of adolescent patients with sacroiliitis to quantify bone inflammation and healing.7 
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Other novel imaging modalities 
Outside MRI, a number of novel imaging modalities for evaluating rheumatological disorders have 
emerged in recent years; these include: 
Fluorescence optical imaging (FOI): This technique involves intravenous administration of a non-
specific fluorophor (typically indocyanine green, ICG), which is excited by light at the dark red 
spectrum. The emitting fluorescence is detected by an optical camera sensor and imaged serially 
every second over a few minutes. Active inflammation is seen as increased fluorescence intensity 
due to increased neovascularity. FOI allows quick overview of active inflammation and has the 
potential to detect subclinical inflammation that is not apparent to clinical examination or 
ultrasound. Unlike ultrasound, it has the advantage of being operator-independent, but is currently 
limited to evaluation of the hand and wrist, and does not provide morphological information.8  
High-resolution peripheral quantitative computed tomography (HR-pQCT): HR-pQCT offers 
extremely high-resolution 3D imaging (typically 82μm isotropic voxel size) of bone structure with 
low radiation dose. The high-resolution and quantitative nature of this technique enables 
assessment of periarticular bone marrow density and cortical/ trabecular microarchitecture for 
detecting early erosive damage.9 
Molecular imaging: The imaging modalities discussed so far – albeit with great promises and 
advances – rely on the detection of anatomical and structural changes related to the disease, and 
are insensitive to the preceding molecular and cellular changes in the very early stages of 
pathogenesis. Molecular imaging is a collective term used to describe techniques that employ 
molecular probes to allow visualisation of the underlying biochemical processes driving the 
disease. Probes are designed to target various disease processes such as inflammation, T/B-cells 
activation, activated macrophages, activated vascular endothelium and apoptosis. To enable 
visualisation of these processes, probes are bound to imaging tracers (typically radiolabelled which 
facilitate detection through tissue penetration) that are detected using modalities such as positron-
emission tomography CT (PET-CT) and single photon emission CT (SPECT). Molecular imaging has 
also shown great potential in the development of personalised therapy; for example, the use 
radiolabelled biologicals such as anti-TNFα and anti-CD20 allows confirmation of presence of these 
targets in a patient, which may aid in predicting and selecting the most efficacious treatment.10  
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 Structural bony changes seen on radiographs reflect late disease, and thus have limited role in 
early diagnosis and disease monitoring. 
 MRI is highly sensitive for detecting early bony changes and synovial inflammation, and is 
becoming more routinely used for early diagnosis, disease/ treatment monitoring and 
prognostication of arthropathies,  
 Novel MR techniques provide new avenue for disease evaluation: WB-MRI facilitates detection 
of inflammation at multiple sites; DWI-, DCE- and CSE-MRI provide quantitative and objective 
assessment of periarticular damage and may aid in standardisation and automation. 
 Other developments include fluorescence optical imaging which provides a quick and non-
invasive overview of active inflammation of extremities, and receptor-specific molecular 
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Figure 1: Whole Body MRI (WB-MRI) of a 22-year-old patient with polyarticular juvenile 
inflammatory arthritis. WB-MRI can image multiple joints facilitating the assessment of the  
distribution and severity of joint inflammation. (a) Large field-of-view image showing enhancing 
active synovitis in the left hip and right knee. Note the asymmetry of the hips with lack of synovial 
enhancement of the right hip.  Magnified views of the diseased left hip (b) and right knee (c), 





Figure 2: MRI of the sacroiliac joints of a 20 year-old patient with Enthesitis Related Arthritis 
and sacroiliitis.  There is marked subchondral osseous oedema on the left joint, with less extensive 
involvement on the right. (a) T1-weighted image showing bone marrow oedema/ osteiits as low 
signal intensity, compared to the normal adjacent fatty marrow which is high signal on T1. (b) STIR, 
fluid sensitive sequence, demonstrating the corresponding foci of osteiitis as high signal regions. (c) 
Diffusion-weighted image (DWI) and (d) apparent diffusion coefficient (ADC) map. Areas of active 
osteiitis are hyperintense on both DWI and ADC images, reflecting unrestricted diffusion (arrowed 
c and d). Blue line – outline of ilium; Orange line – outline of sacrum. 
 
Figure 3 






1. In inflammatory arthritis, which conventional MRI sequence is the most sensitive and specific 
for detection of active synovitis? 
a. T1 
b. Contrast-enhanced T1 
c. T2 
d. Proton density (PD) 
e. STIR 
 
2. An adolescent is referred to the rheumatology clinic for suspected polyarticular juvenile 
idiopathic arthritis. Standard blood test including antibody screening has been performed. The 
clinician is interested in ascertaining the distribution and extent of joint involvement. Which of 
the following imaging modality would be the most appropriate? 
a. Radiography (X-ray) 
b. Ultrasound 
c. Molecular imaging with SPECT 
d. Fluorescence optical imaging (FOI) 
e. Whole-body MRI (WB-MRI) 
 
3. The main potential advantage of molecular imaging over other imaging techniques in the 
evaluation of rheumatological disorders is its: 
a. Lack of ionising radiation 
b. Ability to target pathogenetic molecular pathways  
c. Ability to assess structural changes 
d. Low cost and availability 
e. Non-invasive nature 
 
Answers to self-assessment questions 
1. Answer: (b). Out of the available options, contrast-enhanced T1 sequence is the most sensitive 
and specific for detecting active synovitis, where the increased neovascularity in the actively-
inflamed synovium results in increased contrast-enhancement. Standard T1 sequence is 
insensitive to such change, but has a role in detecting bone marrow oedema (which is seen as 
hypointensity compared to adjacent normal bone marrow).  There are often concurrent 
periarticular soft tissue oedema and joint fluid surrounding the site of active synovitis, to which 
T2, PD and STIR sequences are sensitive to in varying degrees, but these are secondary signs 
and are not as sensitive and specific compared to contrast-enhanced T1 sequence.  
 
2. Answer: (e). WB-MRI, where available, is the most suitable option as it does not involve ionising 
radiation (which should be a major consideration in imaging children and adolescents due to 
increased risk of cancer), can image all joints in a single sitting to provide an overview of 
disease distribution, and allow evaluation of the deep joints of the axial skeleton. Radiography 
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would not be the first choice as the radiation dose of imaging all joints would be prohibitive. 
Ultrasound offers a quick and readily accessible alternative, but is limited by its inability to 
visualise deep joints, and the time needed to image all joints would also be prohibitive.  
Molecular imaging with SPECT also involves a significant ionising radiation dose, is currently 
expensive and is not widely available. Fluorescence optimal imaging is currently limited to the 
hand and wrist, and is not yet widely available. 
 
3. Answer: (b). The uniqueness of molecular imaging lies in its ability to target specific molecular 
and physiological processes that drive the disease, and has the potential to offer further insight 
into the pathogenesis of rheumatological disorders and personalisation of therapy. Most of the 
molecular probes being developed are bound to radiolabelled tracers such as technetium-99m, 
which are then detected using SPECT, thus this technique often involves ionising radiation. It is 
considered developmental and is not in clinical routine use, and production cost remains high.  
All of the imaging modalities discussed in this article are considered non-invasive, and involves 
no more than insertion of a standard cannula for the delivery of contrast agent/ tracer. 
 
 
